leadf
logo-loader
viewMindMed

MindMed takes another step forward adding MDMA to their R&D pipeline

MindMed (OTCQB: MMEDF) CO-CEO Jr Rahn joined Steve Darling from Proactive to announce the company has now added MDMA to its research and development pipeline.

Rahn telling Proactive about some of the clinical studies they are doing including a new one called Project Lucy.

Quick facts: MindMed

Price: 3.095 USD

OTCQB:MMEDF
Market: OTCQB
Market Cap: $1.01 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MindMed named herein, including the promotion by the Company of MindMed in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

O3 Mining sells its Ontario-based Golden Bear assets to Moneta Porcupine...

O3 Mining Inc (CVE:OIII) (OTCQX:OIIIF) CEO Jose Vizquerra tells Proactive the group has agreed to sell its wholly-owned Northern Gold Mining subsidiary to Moneta Porcupine Mines Inc (TSE:ME) (OTCMKTS:MPUCF) (FRA:MOP) in exchange for 149,507,273 Moneta common shares, which would give O3 Mining a...

5 hours, 13 minutes ago

2 min read